Apollo Hospitals

Apollo Hospitals

7,468.50
+105.00
(1.43%)
Market Cap
1,05,875.80 Cr
EPS
100.56
PE Ratio
73.24
Dividend Yield
0.38 %
52 Week High
7,635.00
52 Week Low
6,001.00
PB Ratio
12.91
Debt to Equity
0.74
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from25 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+92.00 %
+92.00 %
Hold
Hold+4.00 %
+4.00 %
Sell
Sell+4.00 %
+4.00 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,280.50
#1 1,23,209.90
108.87
7,184.10
18.77
1,076
26.84
58.90
7,468.50
#2 1,05,875.80
#5 73.24
#1 21,794.00
#6 14.74
#2 1,513
#2 60.41
59.91
845.55
63,911.00
75.81
7,849.70
8.99
809
-7.43
69.70
1,991.60
40,475.70
50.87
5,482.98
10.96
807
3.41
53.26
1,323.10
35,620.10
68.53
3,692.32
#1 25.09
486
-20.35
65.64
761.95
31,585.00
83.81
3,035.10
12.94
409
48.39
64.31
582.40
30,830.80
83.07
4,138.46
22.85
#1 5,417
#1 3,986.36
45.17
1,556.40
16,491.00
69.34
1,566.90
17.46
244
10.57
55.29
1,453.90
9,575.90
#1 50.85
1,290.20
17.77
194
-0.88
41.56
570.00
7,826.80
176.00
2,218.14
12.97
28
-71.06
55.67

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
14.74 %
Net Income Growth
3.32 %
Cash Flow Change
39.46 %
ROE
-7.80 %
ROCE
9.18 %
EBITDA Margin (Avg.)
1.72 %

Quarterly Financial Results

Quarterly Financials
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
2,215
2,415
2,508
2,522
2,582
2,850
2,922
3,125
2,179
2,808
2,781
2,931
4,079
3,725
3,662
3,580
3,812
4,274
4,299
4,322
4,452
4,873
4,880
4,981
5,134
5,633
5,596
5,664
Expenses
1,981
2,141
2,222
2,220
2,218
2,427
2,482
2,542
2,159
2,470
2,370
2,456
3,245
3,102
3,052
3,083
3,317
3,699
3,780
3,814
3,909
4,219
4,237
4,303
4,411
4,774
4,765
4,823
EBITDA
234
274
286
302
364
423
440
583
21
337
411
475
835
623
610
497
495
575
519
508
543
654
643
677
724
859
831
841
Operating Profit %
10 %
11 %
11 %
11 %
14 %
15 %
15 %
13 %
1 %
11 %
14 %
14 %
14 %
17 %
16 %
13 %
13 %
13 %
11 %
11 %
12 %
13 %
13 %
13 %
13 %
15 %
14 %
14 %
Depreciation
95
97
98
105
144
155
157
164
160
149
125
139
141
145
149
166
148
155
153
159
167
163
167
190
177
185
185
211
Interest
76
81
84
85
126
134
137
135
127
122
101
99
95
95
94
95
93
93
100
95
106
111
113
119
116
118
110
115
Profit Before Tax
63
96
103
112
94
134
145
284
-267
66
185
238
599
383
368
236
254
327
266
254
270
379
363
368
430
557
536
516
Tax
39
42
53
39
45
51
55
74
-41
7
51
68
99
116
124
139
-70
114
104
108
97
130
109
110
115
162
157
101
Net Profit
23
54
50
73
49
83
90
210
-226
59
134
170
501
267
243
97
324
213
162
146
173
249
254
258
316
396
379
415
EPS in ₹
2.44
4.56
4.10
6.10
4.11
6.20
6.62
15.77
-14.96
4.33
9.38
11.77
34.03
17.24
15.88
6.27
22.05
14.19
10.67
10.05
11.59
16.20
17.06
17.65
21.23
26.34
25.89
27.10

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
6,479
7,360
8,119
8,613
9,183
11,338
11,417
13,269
14,428
16,753
20,657
Fixed Assets
3,244
3,997
4,591
4,773
4,982
7,432
6,778
8,296
8,520
9,664
10,879
Current Assets
1,939
1,975
2,129
2,220
2,282
2,647
3,641
4,061
4,337
5,280
7,029
Capital Work in Progress
533
562
347
712
822
236
234
46
610
873
771
Investments
146
352
406
352
462
434
1,343
816
574
986
481
Other Assets
2,557
2,448
2,775
2,776
2,918
3,237
3,062
4,112
4,725
5,230
0
Total Liabilities
6,479
7,360
8,119
8,613
9,183
11,338
11,417
13,269
14,428
16,753
20,657
Current Liabilities
1,076
1,250
963
1,567
1,956
2,337
2,038
2,434
3,325
4,665
4,579
Non Current Liabilities
2,159
2,701
3,718
3,662
3,759
5,531
4,577
4,932
4,572
4,768
7,426
Total Equity
3,244
3,409
3,438
3,384
3,469
3,470
4,802
5,903
6,531
7,321
8,212
Reserve & Surplus
3,101
3,262
3,240
3,182
3,264
3,270
4,531
5,551
6,126
6,864
8,140
Share Capital
70
70
70
70
70
70
72
72
72
72
72

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
103
39
-52
24
-20
95
45
158
-113
72
Investing Activities
-759
-888
-1,152
-405
-711
-289
-880
-747
-857
-1,537
Operating Activities
470
597
623
537
905
1,293
1,265
1,696
1,377
1,920
Financing Activities
392
330
477
-109
-215
-910
-340
-792
-633
-311

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
29.82 %
29.82 %
29.82 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.33 %
29.34 %
29.34 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
45.63 %
43.92 %
45.37 %
45.27 %
42.74 %
43.49 %
DIIs
9.16 %
10.84 %
12.24 %
12.13 %
12.45 %
14.89 %
14.59 %
16.56 %
17.76 %
16.31 %
18.60 %
17.97 %
19.55 %
21.14 %
19.95 %
19.98 %
22.29 %
21.34 %
Government
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
0.23 %
Public / Retail
4.07 %
3.99 %
4.24 %
4.03 %
4.27 %
4.48 %
4.23 %
4.13 %
4.04 %
3.90 %
4.04 %
3.70 %
3.74 %
3.81 %
3.62 %
3.65 %
3.81 %
3.98 %
Others
56.73 %
55.13 %
53.47 %
54.29 %
53.73 %
51.07 %
51.63 %
49.75 %
48.64 %
50.23 %
47.80 %
48.76 %
1.52 %
1.57 %
1.50 %
1.54 %
1.60 %
1.62 %
No of Share Holders
67,091
75,153
98,452
99,135
1,26,226
1,46,320
1,35,923
1,31,636
1,31,937
1,20,030
1,31,565
1,19,578
1,30,664
1,27,754
1,19,245
1,27,802
1,34,058
1,41,007

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 6 5 6 6 3 11.75 15 16 0.00
Dividend Yield (%) 0.00 0.56 0.41 0.53 0.21 0.07 0.27 0.24 0.24 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2025 6,923.00 7,469.05
19 Aug 2025 DIVIDEND Dividend
₹ 10.00 /share
19 Aug 2025 6,923.00 7,469.05
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 7,352.50 7,469.05
30 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 May 2025 6,974.00 6,923.00
15 Feb 2025 DIVIDEND Dividend
₹ 9.00 /share
14 Feb 2025 6,790.55 6,266.65
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2025 6,828.10 6,790.55
06 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2024 7,092.60 6,966.30
30 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Aug 2024 6,704.00 6,855.95
17 Aug 2024 DIVIDEND Dividend
₹ 10.00 /share
16 Aug 2024 5,903.45 6,686.90
20 Feb 2024 DIVIDEND Dividend
₹ 6.00 /share
20 Feb 2024 6,179.35 6,656.25
19 Aug 2023 DIVIDEND Dividend
₹ 9.00 /share
18 Aug 2023 4,646.10 4,848.35
24 Feb 2023 DIVIDEND Dividend
₹ 6.00 /share
24 Feb 2023 4,355.10 4,448.85
20 Aug 2022 DIVIDEND Dividend
₹ 11.75 /share
18 Aug 2022 3,524.30 4,135.35
21 Aug 2021 DIVIDEND Dividend
₹ 3.00 /share
18 Aug 2021 3,244.80 4,746.50

Announcements

Board Meeting Intimation for Notice For The Board Meeting8 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 01, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJun 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 30, 2025
Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 30, 2025
Closure of Trading WindowJun 23, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJun 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 31, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 31, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 31, 2025
Outcome Of Board Meeting - Appointment Of Secretarial AuditorsMay 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 30, 2025
Announcement under Regulation 30 (LODR)-Date of payment of DividendMay 30, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 30, 2025
Announcement under Regulation 30 (LODR)-AcquisitionMay 30, 2025
AGM On 29Th August 2025May 30, 2025
Outcome Of Board Meeting - Reappointment Of Executive Directors And Independent DirectorMay 30, 2025
Fixation Of Record DateMay 30, 2025
Board Meeting Outcome for Outcome Of The Board MeetingMay 30, 2025
Audited Financial Results For The Quarter And Year Ended 31St March 2025May 30, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 20, 2025
Merger Of Wholly Owned Subsidiary Of Apollo Hospitals International Limited (AHIL) A Subsidiary Of The Company Into AHIL.May 16, 2025
Board Meeting Intimation for Notice Of Board MeetingMay 06, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Closure of Trading WindowMar 24, 2025
Disclosure Pursuant To Regulation 30 Of SEBI LODRMar 21, 2025
Disclosure Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 As Amended (Listing Regulations)Mar 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)Mar 04, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - RevisedMar 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 04, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 04, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 10, 2025
Integrated Filing (Financial)Feb 10, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 10, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesFeb 10, 2025
Board Meeting Outcome for Outcome Of The Board MeetingFeb 10, 2025
Unaudited Financial Results For Three And Nine Months Ended 31St December 2024Feb 10, 2025
Update on board meetingFeb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2025
Board Meeting Intimation for Notice Of The Board MeetingJan 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 11, 2025

Technical Indicators

RSI(14)
Neutral
55.24
ATR(14)
Volatile
122.61
STOCH(9,6)
Neutral
41.19
STOCH RSI(14)
Neutral
22.93
MACD(12,26)
Bearish
-21.05
ADX(14)
Weak Trend
22.49
UO(9)
Bearish
46.43
ROC(12)
Downtrend And Accelerating
-3.32
WillR(14)
Neutral
-57.04

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Kotak Arbitrage Fund Direct-Growth
0.69%
-177875
-0.17%
0.42%
Invesco India Smallcap Fund Direct - Growth
1.48%
151411
1.48%
1.48%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.00%
-143581
-1.79%
-1.89%
Mirae Asset Midcap Fund Direct - Growth
2.06%
140526
0.59%
0.71%
Mirae Asset Large & Midcap Fund Direct-Growth
1.46%
130615
0.24%
0.17%
Nippon India Vision Large & Mid Cap Direct-Growth
0.80%
68880
0.80%
0.80%
SBI Arbitrage Opportunities Fund Direct-Growth
0.28%
-64125
-0.15%
-0.12%
Invesco India Large & Mid Cap Fund Direct-Growth
2.72%
63622
0.52%
0.32%
Invesco India Arbitrage Fund Direct-Growth
0.26%
-44250
-0.14%
-0.09%
Mirae Asset Multicap Fund Direct - Growth
1.74%
41649
0.76%
0.68%
LIC MF Infrastructure Fund Direct-Growth
2.74%
39867
2.74%
2.74%
HDFC Arbitrage Fund Wholesale Direct-Growth
0.91%
37000
0.15%
0.29%
ICICI Prudential Equity Arbitrage Direct-Growth
0.47%
36250
0.07%
0.12%
Aditya Birla Sun Life Arbitrage Fund Direct-Growth
0.57%
36125
0.09%
0.24%
Invesco India Mid Cap Fund Direct-Growth
2.36%
28599
0.16%
-0.09%
Nippon India Retirement Fund - Wealth Creation Scheme Direct-Growth
0.62%
28000
0.62%
0.62%
Edelweiss Balanced Advantage Fund Direct-Growth
1.03%
27095
0.17%
0.14%
Motilal Oswal Large Cap Fund Direct - Growth
0.00%
-27000
-0.80%
-0.88%
Bandhan Large & Mid Cap Fund Direct-Growth
0.78%
-26622
-0.21%
-1.00%
Mirae Asset Healthcare Fund Direct - Growth
6.37%
20000
0.62%
0.62%
Bandhan Flexi Cap Fund Direct-Growth
0.67%
-20000
-0.17%
-0.30%
Kotak Large Cap Fund Direct-Growth
0.68%
20000
0.15%
0.12%
Edelweiss Arbitrage Fund Direct-Growth
0.56%
-17375
-0.05%
0.03%
Tata India Pharma & Healthcare Fund Direct-Growth
7.19%
16000
0.97%
1.41%
LIC MF Large & Mid Cap Fund Direct-Growth
1.73%
15630
0.38%
0.28%

About Apollo Hospitals

Apollo Hospitals Enterprise Limited (AHEL) is a leading private healthcare provider in Asia. It operates a network of hospitals, pharmacies, primary care clinics, and diagnostic centers. As of March 31, 2023, AHEL had a capacity of 9,957 beds across 70 hospitals in India and overseas. This includes 8,544 beds in 43 owned hospitals, 305 beds in 11 cradles, 257 beds in 11 day care/short surgical stay centers, and 851 beds in 5 hospitals operated through management contracts. The company has expanded through acquisitions, joint ventures, and new facility launches. AHEL has also diversified into health insurance, retail pharmacy, and digital healthcare platforms. The company has undergone various corporate restructurings to optimize its business operations across different healthcare segments.
Chairperson NameShobana Kamineni